Literature DB >> 1501894

Lack of expression of tumor-suppressor genes in human malignant glioma cell lines.

R Godbout1, J Miyakoshi, K D Dobler, R Andison, K Matsuo, M J Allalunis-Turner, H Takebe, R S Day.   

Abstract

Human malignant gliomas (glioblastomas and anaplastic astrocytomas) are the most frequent brain tumors and are associated with a variety of genetic alterations including retinoblastoma (RB) and p53 gene mutations, loss of interferon alpha and beta (IFNA, IFNB) genes and lack of O6-methylguanine-DNA methyltransferase (MGMT) expression. Yet, in the studies performed to date, the relationship between these alterations has not been addressed. In this report, we have studied gene expression in 29 malignant glioma cell lines and have determined that, although loss of the interferon genes and loss of RB, p53 and MGMT mRNAs are frequent events, combinations of genetic alterations involving these four proven or putative tumor-suppressor genes are relatively infrequent. The exception was loss of RB mRNA, which may be associated with lack of MGMT mRNA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1501894

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Authors:  A T Parsa; A J Fiore; P C McCormick; J N Bruce
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Genomic alterations in human glioma cell lines detected by restriction landmark genomic scanning.

Authors:  M Nakamura; N Konishi; S Tsunoda; Y Hiasa; T Tsuzuki; K Takemura; K Kobitsu; T Sakaki
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Amplification of a DEAD box protein gene in retinoblastoma cell lines.

Authors:  R Godbout; J Squire
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

Review 4.  Recent advances in immunobiology of brain tumors.

Authors:  M Tada; N de Tribolet
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

5.  Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins.

Authors:  S Sultana; R Zhou; M S Sadagopan; O Skalli
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

6.  Association between cytoplasmic CRABP2, altered retinoic acid signaling, and poor prognosis in glioblastoma.

Authors:  Rong-Zong Liu; Shuai Li; Elizabeth Garcia; Darryl D Glubrecht; Ho Yin Poon; Jacob C Easaw; Roseline Godbout
Journal:  Glia       Date:  2016-02-19       Impact factor: 7.452

7.  Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors.

Authors:  G Chenevix-Trench; J Kerr; M Friedlander; T Hurst; B Sanderson; M Coglan; B Ward; J Leary; S K Khoo
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

8.  MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways.

Authors:  N Wu; X Lin; X Zhao; L Zheng; L Xiao; J Liu; L Ge; S Cao
Journal:  Br J Cancer       Date:  2013-10-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.